Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features

Gunnar F. Kwakye, Monica M.B. Paoliello, Somshuvra Mukhopadhyay, Aaron B. Bowman and Michael Aschner
Additional contact information
Gunnar F. Kwakye: Neuroscience Department, Oberlin College, Oberlin, OH 44074, USA
Monica M.B. Paoliello: Graduate Program in Public Health, Department of Pathology, Clinical and Toxicological Analysis, Center of Health Science, State University of Londrina, Parana 10011, Brazil
Somshuvra Mukhopadhyay: Division of Pharmacology and Toxicology, College of Pharmacy, Institute for Cellular & Molecular Biology, and Institute for Neuroscience, The University of Texas at Austin, Austin, TX 78712, USA
Aaron B. Bowman: Department of Neurology and Pediatrics, Vanderbilt University, Nashville, TN 37240, USA
Michael Aschner: Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA

IJERPH, 2015, vol. 12, issue 7, 1-22

Abstract: Manganese (Mn) is an essential trace element necessary for physiological processes that support development, growth and neuronal function. Secondary to elevated exposure or decreased excretion, Mn accumulates in the basal ganglia region of the brain and may cause a parkinsonian-like syndrome, referred to as manganism. The present review discusses the advances made in understanding the essentiality and neurotoxicity of Mn. We review occupational Mn-induced parkinsonism and the dynamic modes of Mn transport in biological systems, as well as the detection and pharmacokinetic modeling of Mn trafficking. In addition, we review some of the shared similarities, pathologic and clinical distinctions between Mn-induced parkinsonism and Parkinson’s disease. Where possible, we review the influence of Mn toxicity on dopamine, gamma aminobutyric acid (GABA), and glutamate neurotransmitter levels and function. We conclude with a survey of the preventive and treatment strategies for manganism and idiopathic Parkinson’s disease (PD).

Keywords: manganese-induced parkinsonism; manganese neurotoxicity; Parkinson’s disease (PD); manganism; neurodegenerative diseases (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2015
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
https://www.mdpi.com/1660-4601/12/7/7519/pdf (application/pdf)
https://www.mdpi.com/1660-4601/12/7/7519/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:12:y:2015:i:7:p:7519-7540:d:52112

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().